High-fat diet does not exacerbate aortic pathology and enhances metabolic function in Marfan syndrome Fbn1C1041G/+

Carmen Yap1, Myrthe E Hoogeland2, Siyu Li2

  • 1Amsterdam UMC location University of Amsterdam, Medical Biochemistry, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Abstract

Insights

A high-fat diet did not worsen aortic issues in Marfan syndrome (MFS) mice. This is likely because the diet improved mitochondrial gene expression, boosting energy expenditure in MFS mice.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiovascular Pathology

Background:

  • Marfan syndrome (MFS) is a genetic disorder caused by FBN1 gene variants.
  • MFS patients often exhibit an asthenic body type linked to metabolic changes.
  • Investigating diet's impact on MFS is crucial for understanding disease progression.

Purpose of the Study:

  • To determine the effects of a high-fat diet (HFD) on aortic pathology in a mouse model of Marfan syndrome.
  • To evaluate metabolic alterations in MFS mice fed a HFD.

Main Methods:

  • Male Fbn1C1041G/+ MFS mice and wild-type littermates were fed either a standard chow or a HFD for 13 weeks.
  • Assessed body weight, adipose tissue, glucose tolerance, respiratory exchange ratio, and aortic root diameter.
  • Analyzed mitochondrial gene expression, including Sirt1 levels.

Main Results:

  • HFD increased body weight, adipose tissue, and glucose intolerance in all mice, independent of genotype.
  • MFS mice on chow diet showed increased heart weight, aortic root diameter, and elastin breaks.
  • HFD did not exacerbate aortic dilation in MFS mice but did in wild-type mice.
  • HFD normalized altered mitochondrial gene expression in MFS mice, particularly increasing Sirt1 levels.

Conclusions:

  • A high-fat diet does not aggravate aortic pathology in this Marfan syndrome mouse model.
  • Increased mitochondrial gene expression, especially Sirt1, upon HFD consumption may explain the lack of aortic worsening.
  • These findings suggest a potential role for metabolic interventions in managing MFS complications.